These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 18620895)
21. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. Ogmundsdóttir HM; Björnsson J; Holbrook WP J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450 [TBL] [Abstract][Full Text] [Related]
22. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy. Tatemoto Y; Osaki T; Yoneda K; Yamamoto T; Ueta E; Kimura T Pathol Res Pract; 1998; 194(12):821-30. PubMed ID: 9894247 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of activated Akt expression in oral squamous cell carcinoma. Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112 [TBL] [Abstract][Full Text] [Related]
28. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients. Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910 [TBL] [Abstract][Full Text] [Related]
29. MUC4: a novel prognostic factor of oral squamous cell carcinoma. Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516 [TBL] [Abstract][Full Text] [Related]
30. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798 [TBL] [Abstract][Full Text] [Related]
31. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958 [TBL] [Abstract][Full Text] [Related]
32. Cytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinoma. Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Feb; 22(2):662-9. PubMed ID: 25149434 [TBL] [Abstract][Full Text] [Related]
33. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors. Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477 [TBL] [Abstract][Full Text] [Related]
34. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
35. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma. Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Warnakulasuriya S; Forteza J; Fraga M J Oral Pathol Med; 2012 Aug; 41(7):559-67. PubMed ID: 22417132 [TBL] [Abstract][Full Text] [Related]
36. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma. Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Shah NG; Trivedi TI; Tankshali RA; Goswami JV; Jetly DH; Shukla SN; Shah PM; Verma RJ Head Neck; 2009 Dec; 31(12):1544-56. PubMed ID: 19424974 [TBL] [Abstract][Full Text] [Related]
38. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma. Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345 [TBL] [Abstract][Full Text] [Related]
39. 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer. Ito K; Suzuki T; Akahira J; Sakuma M; Saitou S; Okamoto S; Niikura H; Okamura K; Yaegashi N; Sasano H; Inoue S Clin Cancer Res; 2005 Oct; 11(20):7384-91. PubMed ID: 16243811 [TBL] [Abstract][Full Text] [Related]
40. Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer. Kwon M; Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY; Lee BH Eur J Cancer; 2015 Jan; 51(2):177-85. PubMed ID: 25483786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]